1. Home
  2. BNR vs BNGO Comparison

BNR vs BNGO Comparison

Compare BNR & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • BNGO
  • Stock Information
  • Founded
  • BNR 2014
  • BNGO 2003
  • Country
  • BNR China
  • BNGO United States
  • Employees
  • BNR N/A
  • BNGO N/A
  • Industry
  • BNR Medical Specialities
  • BNGO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • BNR Health Care
  • BNGO Industrials
  • Exchange
  • BNR Nasdaq
  • BNGO Nasdaq
  • Market Cap
  • BNR 29.1M
  • BNGO 24.3M
  • IPO Year
  • BNR 2020
  • BNGO 2018
  • Fundamental
  • Price
  • BNR $3.10
  • BNGO $3.67
  • Analyst Decision
  • BNR
  • BNGO Buy
  • Analyst Count
  • BNR 0
  • BNGO 5
  • Target Price
  • BNR N/A
  • BNGO $7.33
  • AVG Volume (30 Days)
  • BNR 68.0K
  • BNGO 133.0K
  • Earning Date
  • BNR 06-10-2025
  • BNGO 05-14-2025
  • Dividend Yield
  • BNR N/A
  • BNGO N/A
  • EPS Growth
  • BNR N/A
  • BNGO N/A
  • EPS
  • BNR N/A
  • BNGO N/A
  • Revenue
  • BNR $70,669,261.00
  • BNGO $28,464,000.00
  • Revenue This Year
  • BNR $136.32
  • BNGO $0.53
  • Revenue Next Year
  • BNR N/A
  • BNGO $10.22
  • P/E Ratio
  • BNR N/A
  • BNGO N/A
  • Revenue Growth
  • BNR N/A
  • BNGO N/A
  • 52 Week Low
  • BNR $2.18
  • BNGO $2.68
  • 52 Week High
  • BNR $7.90
  • BNGO $61.20
  • Technical
  • Relative Strength Index (RSI)
  • BNR 51.73
  • BNGO 44.71
  • Support Level
  • BNR $2.99
  • BNGO $3.41
  • Resistance Level
  • BNR $3.45
  • BNGO $3.88
  • Average True Range (ATR)
  • BNR 0.34
  • BNGO 0.31
  • MACD
  • BNR 0.10
  • BNGO -0.01
  • Stochastic Oscillator
  • BNR 70.59
  • BNGO 16.88

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

Share on Social Networks: